Neil Garry Arthur
CIK 0001586785
Chief Executive OfficerDirector
Filings
16
Latest May 26, 2026
Issuers covered
4
Showing
16 of 16
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -90.9% | -90.9% | -90.9% | -90.9% |
| 90 days | 1 | 0% | -97.6% | -97.6% | -97.6% | -97.6% |
| 180 days | 1 | 0% | -98.4% | -98.4% | -98.4% | -98.4% |
| 365 days | 1 | 0% | -98.9% | -98.9% | -98.9% | -98.9% |
Issuers
Companies where Neil Garry Arthur has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 10 | May 26, 2026 |
| CLDX | Celldex Therapeutics, Inc. | 4 | Jun 9, 2025 |
| ARNA | Arena Pharmaceuticals Inc | 1 | Mar 11, 2022 |
| ZURA | Zura Bio Ltd | 1 | May 22, 2023 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|